Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

498 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Are We Getting High Cause the Thrill is Gone?
Blum K, Mclaughlin T, Gold MS, Gondre-Lewis MC, Thanos PK, Elman I, Baron D, Bowirrat A, Barh D, Khalsa J, Hanna C, Jafari N, Zeine F, Braverman ER, Dennen C, Makale MT, Makale M, Sunder K, Murphy KT, Badgaiyan RD. Blum K, et al. Among authors: mclaughlin t. J Addict Psychiatry. 2023;7(1):5-516. Epub 2023 Dec 8. J Addict Psychiatry. 2023. PMID: 38164471 Free PMC article.
Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?
Blum K, Dennen CA, Elman I, Bowirrat A, Thanos PK, Badgaiyan RD, Downs BW, Bagchi D, Baron D, Braverman ER, Gupta A, Green R, McLaughlin T, Barh D, Gold MS. Blum K, et al. Among authors: mclaughlin t. J Pers Med. 2022 Oct 14;12(10):1719. doi: 10.3390/jpm12101719. J Pers Med. 2022. PMID: 36294858 Free PMC article.
Proposing FDA consideration for the treatment and prophylaxis of opioid and psychostimulant abuse to incorporate the induction of DNA guided dopamine homeostasis: Anti-reward deficiency restoration solution (ARDS).
Blum K, Giordano J, Baron D, McLaughlin T, Badgaiyan RD. Blum K, et al. Among authors: mclaughlin t. J Syst Integr Neurosci. 2020;8:10.15761/JSIN.1000253. doi: 10.15761/JSIN.1000253. Epub 2020 Dec 15. J Syst Integr Neurosci. 2020. PMID: 36407844 Free PMC article.
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids.
Ceccanti M, Blum K, Bowirrat A, Dennen CA, Braverman ER, Baron D, Mclaughlin T, Giordano J, Gupta A, Downs BW, Bagchi D, Barh D, Elman I, Thanos PK, Badgaiyan RD, Edwards D, Gold MS. Ceccanti M, et al. Among authors: mclaughlin t. J Pers Med. 2022 Dec 6;12(12):2015. doi: 10.3390/jpm12122015. J Pers Med. 2022. PMID: 36556236 Free PMC article. Review.
Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family.
Dennen CA, Blum K, Bowirrat A, Thanos PK, Elman I, Ceccanti M, Badgaiyan RD, McLaughlin T, Gupta A, Bajaj A, Baron D, Downs BW, Bagchi D, Gold MS. Dennen CA, et al. Among authors: mclaughlin t. J Pers Med. 2022 Nov 8;12(11):1864. doi: 10.3390/jpm12111864. J Pers Med. 2022. PMID: 36579592 Free PMC article.
Futuristic Thinking about Engineering "Geneospirituality" to Help Prevent Relapse of Reward Deficiency Syndrome (RDS) Behaviors.
Blum K, McLaughlin T, Bowirrat A, Bagchi D, Braverman ER, Gupta A, Baron D, Thanos PK, Khalsa J, Jafari N, Zeine F, Giordano J, Dennen CA, Madigan MA, Carney P, Gold MS, Sunder K, Badgaiyan RD. Blum K, et al. Among authors: mclaughlin t. EC Psychol Psychiatr. 2023 Feb 16;12(3):26-32. EC Psychol Psychiatr. 2023. PMID: 37361347 Free PMC article.
Dopaminergic dysfunction: Role for genetic & epigenetic testing in the new psychiatry.
Blum K, Ashford JW, Kateb B, Sipple D, Braverman E, Dennen CA, Baron D, Badgaiyan R, Elman I, Cadet JL, Thanos PK, Hanna C, Bowirrat A, Modestino EJ, Yamamoto V, Gupta A, McLaughlin T, Makale M, Gold MS. Blum K, et al. Among authors: mclaughlin t. J Neurol Sci. 2023 Oct 15;453:120809. doi: 10.1016/j.jns.2023.120809. Epub 2023 Sep 23. J Neurol Sci. 2023. PMID: 37774561
The Future is Now for Precision Genomic Addiction Medicine as a Frontline Modality for Inducing "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
Gilley ED, Bowirrat A, Gupta A, Giordano J, A Dennen C, R Braverman E, D Badgaiyan R, McLaughlin T, Baron D, Blum K. Gilley ED, et al. Among authors: mclaughlin t. Curr Pharm Biotechnol. 2023 Apr 27. doi: 10.2174/1389201024666230427111117. Online ahead of print. Curr Pharm Biotechnol. 2023. PMID: 37102488
Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequences.
Blum K, Bowirrat A, Baron D, Elman I, Makale MT, Cadet JL, Thanos PK, Hanna C, Ahmed R, Gondre-Lewis MC, Dennen CA, Braverman ER, Soni D, Carney P, Khalsa J, Modestino EJ, Barh D, Bagchi D, Badgaiyan RD, McLaughlin T, Cortese R, Ceccanti M, Murphy KT, Gupta A, Makale MT, Sunder K, Gold MS. Blum K, et al. Among authors: mclaughlin t. Gene Protein Dis. 2024 Mar 29;3(1):10.36922/gpd.1966. doi: 10.36922/gpd.1966. Gene Protein Dis. 2024. PMID: 38766604 Free PMC article.
498 results